ClinicalTrials.Veeva

Menu

Risk Factors and Deep Learning Model for CI-AKI

X

Xiao Li,MD

Status

Active, not recruiting

Conditions

AKI - Acute Kidney Injury

Study type

Observational

Funder types

Other

Identifiers

NCT06596785
LCYX-LX-20240101

Details and patient eligibility

About

Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent.

Full description

Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent. Despite the frequent use of iodinated contrast agents in medical investigations, predictive models for CI-AKI are scarce. This study aimed to construct and validate interpretable deep learning models for the early risk prediction of acute kidney injury (AKI) associated with iodinated contrast agents.

Enrollment

2,000 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients who received iodinated contrast agents during hospitalization
  • age ≥ 18 years
  • hospitalization length ≥ 48 hours
  • at least two serum creatinine tests during hospitalization

Exclusion criteria

  • patients with stage 4 or 5 chronic kidney disease prior to admission
  • patients undergoing hemodialysis, hemofiltration or peritoneal before admission
  • a history of nephrectomy or kidney transplantation during hospitalization
  • incomplete clinical information
  • Serum creatinine always ≤ 40 μmol/L during hospitalization

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems